Fatatis A - Search Results

1

Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells.

D'Ambrosio J, Fatatis A. D'Ambrosio J, et al. Among authors: fatatis a. Clin Exp Metastasis. 2009;26(8):955-64. doi: 10.1007/s10585-009-9286-3. Epub 2009 Sep 21. Clin Exp Metastasis. 2009. PMID: 19768662

2

CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism.

Jamieson WL, Shimizu S, D'Ambrosio JA, Meucci O, Fatatis A. Jamieson WL, et al. Among authors: fatatis a. Cancer Res. 2008 Mar 15;68(6):1715-22. doi: 10.1158/0008-5472.CAN-07-1315. Cancer Res. 2008. PMID: 18339851 Free PMC article.

3

Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor.

Dolloff NG, Shulby SS, Nelson AV, Stearns ME, Johannes GJ, Thomas JD, Meucci O, Fatatis A. Dolloff NG, et al. Among authors: fatatis a. Oncogene. 2005 Oct 13;24(45):6848-54. doi: 10.1038/sj.onc.1208815. Oncogene. 2005. PMID: 16007172 Free PMC article.

4

Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.

Dolloff NG, Russell MR, Loizos N, Fatatis A. Dolloff NG, et al. Among authors: fatatis a. Cancer Res. 2007 Jan 15;67(2):555-62. doi: 10.1158/0008-5472.CAN-06-2593. Cancer Res. 2007. PMID: 17234763

5

Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche.

Shahriari K, Shen F, Worrede-Mahdi A, Liu Q, Gong Y, Garcia FU, Fatatis A. Shahriari K, et al. Among authors: fatatis a. Oncogene. 2017 May 18;36(20):2846-2856. doi: 10.1038/onc.2016.436. Epub 2016 Dec 19. Oncogene. 2017. PMID: 27991924 Free PMC article.

6

The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.

Russell MR, Liu Q, Lei H, Kazlauskas A, Fatatis A. Russell MR, et al. Among authors: fatatis a. Cancer Res. 2010 May 15;70(10):4195-203. doi: 10.1158/0008-5472.CAN-09-4712. Epub 2010 May 4. Cancer Res. 2010. PMID: 20442296 Free PMC article.

7

The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.

Russell MR, Jamieson WL, Dolloff NG, Fatatis A. Russell MR, et al. Among authors: fatatis a. Oncogene. 2009 Jan 22;28(3):412-21. doi: 10.1038/onc.2008.390. Epub 2008 Oct 13. Oncogene. 2009. PMID: 18850002

8

Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features.

Liu Q, Russell MR, Shahriari K, Jernigan DL, Lioni MI, Garcia FU, Fatatis A. Liu Q, et al. Among authors: fatatis a. Cancer Res. 2013 Jun 1;73(11):3297-305. doi: 10.1158/0008-5472.CAN-12-3970. Epub 2013 Mar 27. Cancer Res. 2013. PMID: 23536554

9

The Bone Microenvironment in Prostate Cancer Metastasis.

DiNatale A, Fatatis A. DiNatale A, et al. Among authors: fatatis a. Adv Exp Med Biol. 2019;1210:171-184. doi: 10.1007/978-3-030-32656-2_9. Adv Exp Med Biol. 2019. PMID: 31900910 Review.

10

CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells.

Shulby SA, Dolloff NG, Stearns ME, Meucci O, Fatatis A. Shulby SA, et al. Among authors: fatatis a. Cancer Res. 2004 Jul 15;64(14):4693-8. doi: 10.1158/0008-5472.CAN-03-3437. Cancer Res. 2004. PMID: 15256432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters